Methotrexate and Etoposide Infusions Into the Fourth Ventricle in Children with Recurrent Posterior Fossa Brain Tumors

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

October 12, 2017

Primary Completion Date

March 4, 2022

Study Completion Date

March 4, 2022

Conditions
Brain Tumor Recurrent
Interventions
DRUG

Methotrexate

Methotrexate 4 mg into fourth ventricle of the brain via the Ommaya Reservoir 2 days a week for 6 weeks. Each patient will have 12 infusions.

DRUG

Etoposide

Etoposide 1 mg into fourth ventricle of the brain via the Ommaya Reservoir 5 days a week for weeks 1, 3, and 5. Each patient will have 15 infusions.

PROCEDURE

Ommaya Reservoir

Surgical catheter placement into the fourth ventricle of the brain

Trial Locations (1)

77030

UTHealth & Children's Memorial Hermann Hospital, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT02905110 - Methotrexate and Etoposide Infusions Into the Fourth Ventricle in Children with Recurrent Posterior Fossa Brain Tumors | Biotech Hunter | Biotech Hunter